Magnetic hyperthermia therapy enhances the chemoradiosensitivity of glioblastoma

Abstract Glioblastoma (GBM) is the most common primary brain cancer and is resistant to standard-of-care chemoradiation therapy (CRT). Magnetic hyperthermia therapy (MHT) exposes magnetic iron oxide nanoparticles (MIONPs) to an alternating magnetic field (AMF) to generate local hyperthermia. This st...

Description complète

Détails bibliographiques

Auteurs principaux:	Daniel Rivera, Alexandros Bouras, Milena Mattioli, Maria Anastasiadou, Anna Chiara Pacentra, Olivia Pelcher, Corrine Koziel, Alexander J. Schupper, Tori Chanenchuk, Hayden Carlton, Robert Ivkov, Constantinos G. Hadjipanayis
Format:	Artigo
Langue:	Inglês
Publié:	Nature Portfolio 2025-03-01
Collection:	Scientific Reports
Sujets:	Glioblastoma Magnetic hyperthermia therapy Magnetic iron-oxide nanoparticles Radiation therapy Temozolomide Chemoradiation
Accès en ligne:	https://doi.org/10.1038/s41598-025-95544-3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!